Brink's Issues Statement on CMA’s Fast-Track Announcement
A number of prospective buyers have expressed preliminary interest in the proposed NoteMachine/TestLink UK sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Brink’s (BCO) has agreed to propose divesting NoteMachine/TestLink UK as part of the CMA review of its NCR Atleos acquisition.
The UK Competition and Markets Authority reached a decision under its fast-track Phase 1 procedure. Brink’s attributes the decision to overlap with NCR Atleos’ Cardtronics business in the UK. The company says the potential sale was contemplated in previously disclosed financial metrics and leaves its expected $200 million in annual run-rate cost synergies—annualized cost savings—unchanged, targeted within three years of closing. The proposed sale process is progressing, and Brink’s expects the acquisition to close early in the first quarter of 2027.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.Expected $200 million in annual run-rate cost synergies within three years of closing remain unchanged by the potential sale.
- Moderate point. Forward-looking: it has not happened yet and may not happen.NCR Atleos acquisition remains on track for early first-quarter 2027 closing, Brink’s expects.
- Minor pointProposed sale process is progressing, with a number of prospective buyers expressing preliminary interest.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.Proposed NoteMachine/TestLink UK divestiture would require Brink’s to sell the business as a regulatory remedy.
- Minor pointCMA review requires continuing engagement following the fast-track Phase 1 decision.
Key Figures
- Annual run-rate cost synergies
- $200 million
- Expected within three years of closing; the proposed UK sale does not impact the target
- Expected acquisition closing
- Early in the first quarter of 2027
- NCR Atleos acquisition remains on track to close
Historical Context
-
Reported Q2 results while reaffirming acquisition timing and the $200 million annual synergy target.
-
Shareholders approved the acquisition; closing remained subject to regulatory approvals and customary conditions.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
divestiture financial
run-rate financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company agrees to propose divestiture of NoteMachine/TestLink UK in connection with CMA review
Acquisition of NCR Atleos remains on track to close early in the first quarter of 2027
RICHMOND, Va., Sept. 30, 2026 (GLOBE NEWSWIRE) -- The Brink's Company (NYSE: BCO) (“Brink’s” or “the Company”) today issued the following statement in connection with the United Kingdom's Competition and Markets Authority ("CMA") Phase 1 decision in relation to the Company’s previously announced agreement to acquire NCR Atleos Corporation (NYSE: NATL) (“NCR Atleos”):
“The CMA’s Phase 1 decision was always contemplated as a potential outcome and reflects the local overlap between Brink’s NoteMachine/TestLink UK business and NCR Atleos’ Cardtronics business in the UK. Brink’s has engaged constructively with the CMA throughout the CMA’s Phase 1 review process, a fact which is reflected in the CMA arriving at today’s decision under its ‘fast-track’ Phase 1 procedure.
The potential sale of NoteMachine/TestLink UK was a remedy that was contemplated in the financial metrics that Brink’s has previously disclosed and does not impact the
Supported by the constructive engagement with the CMA and meaningful progress in the proposed divestiture, the NCR Atleos acquisition remains on track to close early in the first quarter of 2027.”
About The Brink’s Company
The Brink’s Company (NYSE: BCO) is a leading global provider of cash and valuables management, digital retail solutions, and ATM managed services. Our customers include financial institutions, retailers, government agencies, mints, jewelers and other commercial operations. Our network of operations in 51 countries serves customers in more than 100 countries. For more information, please visit our website at www.brinks.com.
Forward-Looking Statements
This release contains forward-looking information. Words such as "anticipate," "assume," "estimate," "expect," “target,” "project," "predict," "intend," "plan," "believe," "potential," "may," "should" and similar expressions may identify forward-looking information. Forward-looking information in this release includes, but is not limited to statements regarding the proposed acquisition of NCR Atleos, the anticipated divestiture of NoteMachine/TestLink UK, the timing and outcome of regulatory reviews and approvals, the expected timing of closing of the transaction, and anticipated transaction benefits and synergies. These statements are based on current expectations and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed or implied by such statements.
Forward-looking statements in this document are subject to known and unknown risks, uncertainties and contingencies, which are difficult to predict or quantify, and which could cause actual results, performance or achievements to differ materially from those that are anticipated. These risks, uncertainties and contingencies, many of which are beyond our control, include, but are not limited to: our ability to obtain required regulatory approvals and satisfy other closing conditions; the timing and terms of any divestiture transaction; the possibility that the proposed acquisition is delayed or not completed; risks related to the integration of NCR Atleos and the realization of anticipated benefits and synergies; transaction-related costs and disruptions; and other risks described in the Company’s filings with the Securities and Exchange Commission.
This list of risks, uncertainties and contingencies is not intended to be exhaustive. Additional factors that could cause our results to differ materially from those described in the forward-looking statements can be found under "Risk Factors" in Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2025, and in the registration statement on Form S-4 filed in connection with the proposed acquisition of NCR Atleos, and in related disclosures in our other public filings with the Securities and Exchange Commission. The forward-looking information included in this document is representative only as of the date of this document and The Brink's Company undertakes no obligation to update, revise or clarify any information contained in this document or forward-looking statements that may be made from time to time on our behalf, whether as a result of new information, future events or otherwise, except as required by law.
Contacts
Investor Inquiries
Jesse Jenkins
jesse.jenkins@brinksinc.com
Media Inquiries
Kelly McNeff
(469) 549-6555
brinksmedia@brinks.com
OR
FGS Global
brinks@fgsglobal.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When does Brink’s expect its NCR Atleos acquisition to close?
Brink’s expects the NCR Atleos acquisition to close early in the first quarter of 2027. The transaction remains on track while the proposed NoteMachine/TestLink UK divestiture process progresses.
Does Brink’s proposed UK divestiture change its expected NCR Atleos cost savings?
Brink’s says the potential NoteMachine/TestLink UK sale does not change its expected $200 million in annual run-rate cost synergies, targeted within three years of closing. These are annualized cost savings, and the potential sale was already contemplated in previously disclosed financial metrics.